您的位置: 首页 > 农业专利 > 详情页

THERAPEUTIC AGENT FOR TUMORS IDENTIFIED BY PHOSPHORYLATION OF PROTO-ONCOGENE PROTEIN BELONGING TO VAV FAMILY
专利权人:
University of Tsukuba
发明人:
Shigeru CHIBA,Mamiko YANAGIMOTO
申请号:
US16393138
公开号:
US20200069684A1
申请日:
2019.04.24
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention provides a therapeutic agent and others for various tumors including angioimmunoblastic T-cell lymphoma (AITL), which is an orphan disease. The present invention relates to a therapeutic agent and others for tumors identified by phosphorylation of a proto-oncogene protein belonging to the VAV family, which comprises dasatinib or a prodrug thereof or a pharmacologically acceptable salt thereof or a hydrate or solvate thereof as an active ingredient.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充